TABLE 1.
Baseline Patient Characteristics | Enrolled (N=5) Mean (s.d.) | |||||
---|---|---|---|---|---|---|
Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 | ||
Completers | 4 | Yes | Yes | Yes | No | Yes |
Schizophrenia Diagnosis | 4 | Yes | Yes | Yes | Yes | |
Schizoaffective Bipolar Type | 1 | Yes | ||||
Deficit Syndrome | 4 | Yes | No | Yes | Yes | No |
History Depression | 4 | Yes | No | Yes | Yes | Yes |
History suicide attempt | 1 | No | No | No | No | Yes |
History substance abuse | 2 | Yes | No | No | No | Yes |
Number women | 2 | Male | Female | Female | Male | Male |
Age | 27.6 (2.2) | 26 | 34 | 30 | 24 | 24 |
Age of psychosis onset | 18.8 (2.0) | 19 | 14 | 25 | 19 | 17 |
Years of Education | 13.2 (1.2) | 12 | 17 | 11 | 12 | 14 |
Chlorpromazine equivalents | 412.8 (74.6) | 550 | 300 | 600 | 280 | 300 |
Number medications | 2.8 | 3 | 2 | 1 | 5 | |
Number medication types | 2.4 (0.6) | 2 | 2 | 1 | 3 | 4 |
Typical antipsychotic | N=3 | 1 | 1 | 1 | ||
Atypical antipsychotic | N=3 | 1 | 1 | 1 | 1 | |
Anticholinergic | N=2 | 1 | 1 | |||
Antidepressant | N=2 | 1 | 1 | |||
Mood stabilizer | N=1 | 1 | ||||
Benzodiazepine | N=1 | 1 | ||||
Other | N=1 | 1 | ||||
Simpson Angus Rating Scale | 1.4 (0.6) | 1 | 3 | 2 | 1 | |
PANSS | ||||||
Positive | 16.2 (2.6) | 23 | 19 | 11 | 17 | 11 |
Negative | 28.8 (2.6) | 32 | 28 | 33 | 31 | 20 |
General | 36.6 (3.9) | 46 | 42 | 26 | 36 | 33 |
Total | 81.6 (7.4) | 101 | 89 | 70 | 84 | 64 |
HAM-D (17 item) | 9.4 (2.8) | 7 | 12 | 4 | 18 | 6 |
SAS | 59.8 (10.8) | 68 | 67 | 49 | 69 | 47 |
CGI | 5.0 (0.7) | 6 | 6 | 4 | 6 | 3 |
GAF | 47.0 (4.2) | 40 | 40 | 50 | 45 | 60 |
Motor Threshold | 56.6 (7.7) | 52 | 37 | 76 | 68 | 50 |
PANSS, Positive and Negative Syndrome Scale; HAM-D, Hamilton Depression Scale; CGI, Clinical Global Impressions; GAF, Global Assessment Factor; SAS, Social Adjustment Scale.